Year: 2009
Type: article
Abstract: Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat and, despite all efforts, median overall survival (mOS) remains at approximately 12 months [1]. Neurological morbidity a...
DOI: 10.1586/era.09.24
Authors: Melike Mut, David Schiff
Institutions: Hacettepe University, University of Virginia
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2067972091